Was AstraZeneca Smart to Sell Its Moderna Shares?
AstraZeneca (NASDAQ: AZN) ranked as one of the earliest and biggest investors in Moderna (NASDAQ: MRNA). But now, the big British drugmaker has reportedly sold all of its shares of the up-and-coming biotech. In this Motley Fool Live video recorded on March 3, 2021, Fool.com contributors Keith Speights and Brian Orelli discuss whether or not AstraZeneca was smart to sell its stake in Moderna and if other investors should follow suit.
Source Fool.com
